![](https://investorshub.advfn.com/uicon/220347.png?cb=1693474201)
Tuesday, January 17, 2017 4:28:08 PM
IMO instead I think what were seeing here is what can happen when the person running the show is a former top Wall Street biotechnology analyst and has the connections to go with it.
Now combine that with a fantastic looking company, with an extremely strong pipeline of drugs, a $100M nanotechnology/transdermal platform and currently conducting research and development into nano and transdermal cannabinoids(see Zynerba (NASDAQ: ZYNE currently sitting @ $19.50 pps) and I think you'll understand the interest.
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM